M. Liu, C. W. Chan, I. Mcgilvray, Q. Ning, and G. A. Levy, Fulminant viral hepatitis: molecular and cellular basis, and clinical implications, Expert. Rev. Mol. Med, pp.1-19, 2001.

J. Polson and W. M. Lee, AASLD position paper: the management of acute liver failure, Hepatology, vol.41, pp.1179-1197, 2005.

P. Manka, J. Verheyen, G. Gerken, and A. Canbay, Liver failure due to acute viral hepatitis (A-E), Visc. Med, vol.32, pp.80-85, 2016.

M. Mendizabal and M. O. Silva, Liver transplantation in acute liver failure: a challenging scenario, World J. Gastroenterol, vol.22, pp.1523-1531, 2016.

H. R. Rosen and P. Martin, Viral hepatitis in the liver transplant recipient, Infect. Dis. Clin, vol.14, pp.761-784, 2000.

M. Pope, Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication, J. Virol, vol.69, pp.5252-5260, 1995.

L. Alexopoulou, A. C. Holt, R. Medzhitov, and R. A. Flavell, Recognition of doublestranded RNA and activation of NF-kappaB by Toll-like receptor 3, Nature, vol.413, pp.732-738, 2001.

L. Dejager and C. Libert, Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice, Cytokine, vol.42, pp.55-61, 2008.

Y. Chen, Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection, PLoS Pathog, vol.7, p.1001347, 2011.

J. P. Martin, W. Chen, F. Koehren, and C. A. Pereira, The virulence of mouse hepatitis virus 3, as evidenced by permissivity of cultured hepatic cells toward escape mutants, Res. Virol, vol.145, pp.297-302, 1994.

A. Jacques, C. Bleau, J. P. Martin, and L. Lamontagne, Intrahepatic endothelial and Kupffer cells involved in immunosuppressive cytokines and natural killer (NK)/NK T cell disorders in viral acute hepatitis, Clin. Exp. Immunol, vol.152, pp.298-310, 2008.

A. Jacques, C. Bleau, C. Turbide, N. Beauchemin, and L. Lamontagne, Macrophage interleukin-6 and tumour necrosis factor-alpha are induced by coronavirus fixation to Toll-like receptor 2/heparan sulphate receptors but not carcinoembryonic cell adhesion antigen 1a, Immunology, vol.128, pp.181-192, 2009.

C. Bleau, A. Filliol, M. Samson, and L. Lamontagne, Mouse hepatitis virus infection induces a toll-like receptor 2-dependent activation of inflammatory functions in liver sinusoidal endothelial cells during acute hepatitis, J. Virol, vol.90, pp.9096-9113, 2016.

S. Belouzard, J. K. Millet, B. N. Licitra, and G. R. Whittaker, Mechanisms of coronavirus cell entry mediated by the viral spike protein, Viruses, vol.4, pp.1011-1033, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02652528

S. Palchetti, Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells, J. Biol. Chem, vol.290, pp.5470-5483, 2015.

L. Zhang, Interferon beta (IFN-beta) production during the doublestranded RNA (dsRNA) response in hepatocytes involves coordinated and feedforward signaling through toll-like receptor 3 (TLR3), RNA-dependent protein kinase (PKR), inducible nitric oxide synthase (iNOS), and Src protein, J. Biol. Chem, vol.291, pp.15093-15107, 2016.

J. Han, C. Q. Zhong, and D. W. Zhang, Programmed necrosis: backup to and competitor with apoptosis in the immune system, Nat. Immunol, vol.12, pp.1143-1149, 2011.

F. Humphries, S. Yang, B. Wang, and P. N. Moynagh, RIP kinases: key decision makers in cell death and innate immunity, Cell Death Differ, vol.22, pp.225-236, 2015.

B. Feng, Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure, J. Proteome Res, vol.6, pp.2161-2167, 2007.

M. I. Arshad, Pathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitis, PLoS ONE, vol.8, p.74278, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00874120

M. A. Kelliher, The death domain kinase RIP mediates the TNF-induced NF-kappaB signal, Immunity, vol.8, pp.297-303, 1998.

M. Pasparakis and P. Vandenabeele, Necroptosis and its role in inflammation, Nature, vol.517, pp.311-320, 2015.

A. Filliol, RIPK1 protects from TNF-alpha-mediated liver damage during hepatitis, Cell Death Dis, vol.7, p.2462, 2016.

A. Filliol, RIPK1 protects hepatocytes from Kupffer cells-mediated TNFinduced apoptosis in mouse models of PAMP-induced hepatitis, J. Hepatol, vol.66, pp.1205-1213, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01532060

A. Filliol, RIPK1 protects hepatocytes from death in Fas-induced hepatitis, Sci. Rep, vol.7, p.9205, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01579612

J. Suda, Knockdown of RIPK1 markedly exacerbates murine immunemediated liver injury through massive apoptosis of hepatocytes, independent of necroptosis and inhibition of NF-kappaB, J. Immunol, vol.197, pp.3120-3129, 2016.

T. Van, Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis, J. Clin. Invest, vol.127, pp.2662-2677, 2017.

C. Li, Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection, J. Exp. Med, vol.176, pp.689-697, 1992.

P. A. Marsden, The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis, J. Clin. Invest, vol.112, pp.58-66, 2003.

Q. Ning, The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene, J. Biol. Chem, vol.274, pp.9930-9936, 1999.

M. Liu, Cytokine-induced hepatic apoptosis is dependent on FGL2/ fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements, J. Immunol, vol.176, pp.7028-7038, 2006.

H. Xu, H. Li, D. Cao, Y. Wu, and Y. Chen, Tumor necrosis factor alpha (TNF-alpha) receptor-I is required for TNF-alpha-mediated fulminant virus hepatitis caused by murine hepatitis virus strain-3 infection, Immunol. Lett, vol.158, pp.25-32, 2014.

C. Yang, Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3, Gut, vol.62, pp.1204-1213, 2013.

Y. Zou, Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/ NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure, J. Immunol, vol.184, pp.466-475, 2010.

W. J. Kaiser, Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL, J. Biol. Chem, vol.288, pp.31268-31279, 2013.

D. Cuchet-lourenco, Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation, Science, vol.361, pp.810-813, 2018.

C. P. Dillon, RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3, Cell, vol.157, pp.1189-1202, 2014.

L. Dara, Z. Liu, and N. Kaplowitz, Questions and controversies: the role of necroptosis in liver disease, Cell Death Discov, vol.2, p.16089, 2016.

C. Günther, The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis, J. Clin. Invest, vol.126, pp.4346-4360, 2016.

C. Yao, Expression and genetic polymorphism of necroptosis related protein RIPK1 is correlated with severe hepatic ischemia-reperfusion injury and prognosis after hepatectomy in hepatocellular carcinoma patients, Cancer Biomark, vol.20, pp.23-29, 2017.

C. Bleau, Toll-like receptor-2 exacerbates murine acute viral hepatitis, Immunology, vol.149, pp.204-224, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01373946

N. Van-rooijen and A. Sanders, Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications, J. Immunol. Methods, vol.174, pp.83-93, 1994.

A. R. Fehr, The nsp3 macrodomain promotes virulence in mice with coronavirus-induced encephalitis, J. Virol, vol.89, pp.1523-1536, 2015.